Resumen

PEREZ-ORPINEL, Oscar A et al. Case report: COVID-19 mRNA vaccine association with acute myocarditis. Cardiovasc. metab. sci [online]. 2022, vol.33, n.2, pp.69-72.  Epub 29-Mayo-2023. ISSN 2954-3835.  https://doi.org/10.35366/105821.

A 50-year-old woman presented to the Emergency Department with chest pain, the elevation of cardiac enzymes, and no electrocardiographic alterations. Coronary angiography was performed in which no obstructive lesions were found. A cardiac magnetic resonance study reported an image consistent with acute myocarditis without evidence of myocardial ischemia. The patient received the first dose of Pfizer-BioNTech vaccine two days before the onset of symptoms. In most cases of myocarditis, its clinical manifestations lie in a wide spectrum, and the etiological diagnosis is indeterminate. In recent months, the probable association between cases of myocarditis with COVID-19 mRNA vaccines has been established. The use of the COVID-19 mRNA vaccine has demonstrated significant benefits in reducing morbidity and mortality related to SARS-CoV-2 virus infection. This event may be a transitory process that does not represent a contraindication for the application of the vaccine.

Palabras llave : Acute myocarditis; COVID-19; mRNA vaccine; ESAVI.